A carregar...
Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease
Alzheimer’s disease (AD) affects more than twenty-five million people worldwide and is the most common form of dementia. Symptomatic treatments have been developed, but effective intervention to alter disease progression is needed. Targets have been identified for disease-modifying drugs, but the re...
Na minha lista:
| Publicado no: | J Neural Transm |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4305447/ https://ncbi.nlm.nih.gov/pubmed/22354745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00702-012-0772-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|